株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血糖モニタリングシステムの世界市場予測 2022年:セルフモニタリング血糖システム・持続的血糖モニタリングシステム

Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 593777
出版日 ページ情報 英文 186 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.05円で換算しております。
Back to Top
血糖モニタリングシステムの世界市場予測 2022年:セルフモニタリング血糖システム・持続的血糖モニタリングシステム Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022
出版日: 2017年12月14日 ページ情報: 英文 186 Pages
概要

世界の血糖モニタリングシステム市場規模は、2017年の83億5,000万米ドルから2022年までに105億8,000万米ドルへ達すると予測され、予測期間中のCAGR (年間複合成長率) は4.8%が見込まれています。同市場の成長を促進する主な要因は、糖尿病患者の増加、および製品発売数の増加です。しかし、高額なコストおよび不十分な医療費償還は、予測期間中の同市場の成長を抑制すると予測されています。

当レポートでは、世界の血糖モニタリングシステム市場について調査し、市場および産業の概要、各セグメント・地域別の市場規模の推移と予測、市場成長への各種影響因子および市場機会の分析、競合環境と市場シェア、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の血糖モニタリングシステム:市場概要
  • 世界の血糖モニタリングシステム市場:製品別
  • 地域分析:世界のセルフモニタリング/従来型血糖システム市場、コンポーネント別
  • 世界の持続的血糖モニタリングシステム市場:コンポーネント別
  • 世界の血糖モニタリングシステム市場:患者ケア状況別
  • 世界の血糖モニタリングシステム市場:用途別
  • 世界の血糖モニタリングシステム市場:試験サイト別
  • 世界の血糖モニタリングシステム市場:地域概要

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題

第6章 血糖モニタリングシステム市場:製品別

  • イントロダクション
  • セルフモニタリング血糖システム
    • 血糖メーター
    • 試験ストリップ
    • ランセット & ランシングデバイス
  • 持続的血糖モニタリングシステム
    • センサー
    • トランスミッター
    • レシーバー

第7章 血糖モニタリングシステム市場:試験サイト別

  • イントロダクション
  • フィンガーチップ試験
  • 代替サイト試験

第8章 血糖モニタリングシステム市場:患者ケア状況別

  • イントロダクション
  • セルフケア/在宅医療
  • 病院 & クリニック

第9章 血糖モニタリングシステム市場:用途別

  • イントロダクション
  • 糖尿病
    • 2型糖尿病
    • 1型糖尿病
    • 妊娠糖尿病

第10章 血糖モニタリングシステム市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋 (APAC)
  • その他 (ROW)

第11章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況

第12章 企業プロファイル

  • ABBOTT LABORATORIES
  • F. HOFFMANN-LA ROCHE
  • LIFESCAN
  • ASCENSIA DIABETES CARE
  • DEXCOM
  • MEDTRONIC
  • YPSOMED
  • B. BRAUN MELSUNGEN
  • NIPRO
  • SANOFI
  • ARKRAY
  • PRODIGY DIABETES CARE
  • ACON LABORATORIES
  • NOVA BIOMEDICAL

第13章 付録

目次
Product Code: MD 5831

"The blood glucose monitoring system market projected to grow at a CAGR of 4.8%."

The global blood glucose monitoring system market is projected to reach USD 10.58 billion by 2022 from an estimated USD 8.35 billion in 2017, at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include rising prevalence of diabetic population, and increasing product launches. However, the high cost and poor reimbursements is expected to restrain the growth of this market during the forecast period.

"By patient care setting, the self/home care segment is expected to grow at the highest CAGR during the forecast period (2017-2022)."

Based on patient care setting, the market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market. This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.

"By application, the type 1 diabetes segment is expected to grow at the highest CAGR during the forecast period (2017-2022)."

Based on application, the market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes.

The type 1 diabetes segment is expected to grow at a highest CAGR owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.

"North America to witness the highest growth during the forecast period (2017-2022)"

North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-50%, Tier 2-30% and Tier 3-20%
  • By Designation - C-level-30%, Director Level-48%, Others-22%
  • By Region - North America-48%, Europe-20%, Asia Pacific-25%, Row-7%

The key players in the global blood glucose monitoring system market are: Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).`

Research Coverage:

The report analyzes the blood glucose monitoring system market and aims at estimating the market size and future growth potential of this market based on various segments such as product, testing site, patient care setting, application, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the blood glucose monitoring system market. The report analyzes the market based on product, testing site, patient care setting, application
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the blood glucose monitoring system market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various blood glucose monitoring system across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the blood glucose monitoring system market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the blood glucose monitoring system market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DESIGN
  • 2.2. RESEARCH APPROACH
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS: MARKET OVERVIEW
  • 4.2. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT
  • 4.3. GEOGRAPHIC ANALYSIS: GLOBAL SELF-MONITORING/ TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT
  • 4.4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
  • 4.5. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
  • 4.6. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION
  • 4.7. GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE
  • 4.8. GEOGRAPHIC SNAPSHOT: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing prevalence of diabetes
      • 5.2.1.2. Increasing number of product launches
    • 5.2.2. RESTRAINT
      • 5.2.2.1. High cost and poor reimbursement of blood glucose monitoring systems and supplies
    • 5.2.3. OPPORTUNITY
      • 5.2.3.1. Pipeline products and ongoing research
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Invasiveness of blood glucose monitors

6. BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SELF-MONITORING BLOOD GLUCOSE SYSTEMS
    • 6.2.1. BLOOD GLUCOSE METERS
    • 6.2.2. TESTING STRIPS
    • 6.2.3. LANCETS & LANCING DEVICES
  • 6.3. CONTINUOUS GLUCOSE MONITORING SYSTEMS
    • 6.3.1. SENSORS
    • 6.3.2. TRANSMITTERS
    • 6.3.3. RECEIVERS

7. BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE

  • 7.1. INTRODUCTION
  • 7.2. FINGERTIP TESTING
  • 7.3. ALTERNATE SITE TESTING

8. BLOOD GLUCOSE MONITORING SYSTEMS MARKET,

BY PATIENT CARE SETTING 62

  • 8.1. INTRODUCTION
  • 8.2. SELF/HOME CARE
  • 8.3. HOSPITALS & CLINICS

9. BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DIABETES
    • 9.2.1. TYPE 2 DIABETES
      • 9.2.1.1. Adults
      • 9.2.1.2. Pediatrics
    • 9.2.2. TYPE 1 DIABETES
      • 9.2.2.1. Adults
      • 9.2.2.2. Pediatrics
    • 9.2.3. GESTATIONAL DIABETES

10. BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. UK
    • 10.3.3. FRANCE
    • 10.3.4. REST OF EUROPE (ROE)
  • 10.4. ASIA PACIFIC (APAC)
    • 10.4.1. CHINA
    • 10.4.2. INDIA
    • 10.4.3. JAPAN
    • 10.4.4. REST OF APAC
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
    • 11.2.1. SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET
    • 11.2.2. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • 11.3. COMPETITIVE SCENARIO
    • 11.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 11.3.2. AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
    • 11.3.3. EXPANSIONS
    • 11.3.4. ACQUISITIONS

12. COMPANY PROFILES (Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 12.1. ABBOTT LABORATORIES
  • 12.2. F. HOFFMANN-LA ROCHE
  • 12.3. LIFESCAN
  • 12.4. ASCENSIA DIABETES CARE
  • 12.5. DEXCOM
  • 12.6. MEDTRONIC
  • 12.7. YPSOMED
  • 12.8. B. BRAUN MELSUNGEN
  • 12.9. NIPRO
  • 12.10. SANOFI
  • 12.11. ARKRAY
  • 12.12. PRODIGY DIABETES CARE
  • 12.13. ACON LABORATORIES
  • 12.14. NOVA BIOMEDICAL

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20-79 YEARS), 2017 VS. 2045
  • TABLE 2: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 3: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 4: SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 5: BLOOD GLUCOSE METERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: BLOOD GLUCOSE METERS MARKET, BY REGION, 2015-2022 (THOUSAND UNITS)
  • TABLE 7: TESTING STRIPS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: TESTING STRIPS MARKET, BY REGION, 2015-2022 (THOUSAND UNITS)
  • TABLE 9: LANCING DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: LANCING DEVICES MARKET, BY REGION, 2015-2022 (THOUSAND UNITS)
  • TABLE 11: LANCETS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: LANCETS MARKET, BY REGION, 2015-2022 (THOUSAND UNITS)
  • TABLE 13: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 14: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 15: SENSORS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 16: SENSORS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 17: TRANSMITTERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: TRANSMITTERS MARKET, BY REGION, 2015-2022 (THOUSAND UNITS)
  • TABLE 19: RECEIVERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: RECEIVERS MARKET, BY REGION, 2015-2022 (THOUSAND UNITS)
  • TABLE 21: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 22: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR FINGERTIP TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR ALTERNATE SITE TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 25: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOME/SELF CARE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 28: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 29: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN ADULTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN PEDIATRICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 33: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN ADULTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN PEDIATRICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR GESTATIONAL DIABETES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 42: NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 44: NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: FDA APPROVALS OF BLOOD GLUCOSE MONITORING SYSTEMS (2014-2017)
  • TABLE 48: US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 49: US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 50: US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 51: US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 52: US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 53: US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 54: US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 55: US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 56: QUANTITY LIMITS FOR BLOOD GLUCOSE TEST STRIPS
  • TABLE 57: CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 58: CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 59: CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 60: CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 61: CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 62: CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 63: CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 64: CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 65: EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 66: EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 68: EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 69: EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 70: EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 71: EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 72: EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 73: EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 74: GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 75: GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 76: GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 77: GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 78: GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 79: GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 80: GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 81: GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 82: UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 84: UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 85: UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 86: UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 87: UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 88: UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 89: UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 90: FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 91: FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 92: FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 93: FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 94: FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 95: FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 96: FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 97: FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 98: ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 99: ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 100: ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 101: ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 102: ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 103: ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 104: ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 105: ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 106: DIABETES PREVALENCE IN APAC, BY COUNTRY
  • TABLE 107: APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 108: APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 109: APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 110: APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 111: APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 112: APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 113: APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 114: APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 115: APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 116: CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 117: CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 118: CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 119: CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 120: CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 121: CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 122: CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 123: CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 124: INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 125: INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 126: INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 127: INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 128: INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 129: INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 130: INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 131: INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 132: JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 133: JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 134: JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 135: JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 136: JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 137: JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 138: JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 139: JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 140: ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 141: ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 142: ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 143: ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 144: ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 145: ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 146: ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 147: ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 148: CONFERENCE IN AFRICA, BRAZIL, AND THE MIDDLE EAST (2015-2017)
  • TABLE 149: ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 150: ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 151: ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 152: ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (USD MILLION)
  • TABLE 153: ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015-2022 (THOUSAND UNITS)
  • TABLE 154: ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015-2022 (USD MILLION)
  • TABLE 155: ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015-2022 (USD MILLION)
  • TABLE 156: ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 157: PRODUCT LAUNCHES AND APPROVALS (2014-2017)
  • TABLE 158: AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
  • TABLE 159: EXPANSIONS
  • TABLE 160: ACQUISITIONS

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 2: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: SECONDARY SOURCES
  • FIGURE 4: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: PRIMARY SOURCES
  • FIGURE 7: KEY INDUSTRY INSIGHTS
  • FIGURE 8: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 9: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 10: DATA TRIANGULATION METHODOLOGY
  • FIGURE 11: SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE GLOBAL MARKET IN 2017
  • FIGURE 12: TESTING STRIPS TO DOMINATE THE SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT (2017)
  • FIGURE 13: SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT (2017)
  • FIGURE 14: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING (2017)
  • FIGURE 15: TYPE 2 DIABETES TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION (2017)
  • FIGURE 16: FINGERTIP TESTING TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE IN 2017
  • FIGURE 17: NORTH AMERICA IS SLATED TO WITNESS THE HIGHEST MARKET GROWTH IN THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: PRODUCT ENHANCEMENTS IN BLOOD GLUCOSE MONITORING SYSTEMS AND GROWING DIABETIC POPULATION ARE DRIVING MARKET GROWTH
  • FIGURE 19: SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT IN 2017
  • FIGURE 20: TESTING STRIPS TO DOMINATE THE GLOBAL SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET IN 2017
  • FIGURE 21: SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET IN 2017
  • FIGURE 22: SELF/HOME CARE TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 23: TYPE 2 DIABETES TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 24: FINGERTIP TESTING TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 25: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 26: CONTINUOUS GLUCOSE MONITORING SYSTEMS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 27: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 28: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
  • FIGURE 29: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 30: NORTH AMERICA TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 31: NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 32: EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 33: DIABETES UK: FUNDS RAISED VS. FUNDS INVESTED
  • FIGURE 34: ASIA-PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 35: ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 36: SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 37: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 38: STRATEGIES ADOPTED BY MARKET PLAYERS (2014-2017)
  • FIGURE 39: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 40: F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2016)
  • FIGURE 41: DEXCOM: COMPANY SNAPSHOT (2016)
  • FIGURE 42: MEDTRONIC: COMPANY SNAPSHOT (2016)
  • FIGURE 43: YPSOMED: COMPANY SNAPSHOT (2016)
  • FIGURE 44: B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 45: NIPRO: COMPANY SNAPSHOT (2016)
  • FIGURE 46: SANOFI: COMPANY SNAPSHOT (2016)
Back to Top